Drug profile · INN
glycopyrronium tosylate
GLYCOPYRRONIUM TOSYLATE
glycopyrronium tosylate (GLYCOPYRRONIUM TOSYLATE) is a muscarinic acetylcholine receptor inhibitor. Route of administration: topical. Current US regulatory status: approved.
Drug details — glycopyrronium tosylate
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 4
- Programs
- 1
- Data quality
- 0.84
Quick answer
glycopyrronium tosylate (GLYCOPYRRONIUM TOSYLATE) is a muscarinic acetylcholine receptor inhibitor. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor inhibitor
Primary target: Muscarinic acetylcholine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is glycopyrronium tosylate?
glycopyrronium tosylate (GLYCOPYRRONIUM TOSYLATE) is a muscarinic acetylcholine receptor inhibitor. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for glycopyrronium tosylate?
GLYCOPYRRONIUM TOSYLATE is a marketed brand name for glycopyrronium tosylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of glycopyrronium tosylate?
glycopyrronium tosylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.